English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17938/22957 (78%)
Visitors : 7397420      Online Users : 223
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/11186


    Title: Paeonia lactiflora Pall inhibits bladder cancer growth involving phosphorylation of Chk2 in vitro and in vivo.
    Authors: Ou, TT
    Wu, CH
    Hsu, JD
    Chyau, CC
    Lee, HJ
    Wang, CJ
    Contributors: 中山醫學大學
    Date: 2011
    Issue Date: 2015-07-13T05:09:29Z (UTC)
    ISSN: 0378-8741
    Abstract: ETHNOPHARMACOLOGICAL RELEVANCE:
    Extracts of Paeonia lactiflora Pall (RPA), a traditional Chinese medicines has been shown to treat cancers.
    AIM OF THE STUDY:
    The purpose of this study is to evaluate the anticancer effect of RPA in urinary bladder carcinoma in vitro and in vivo.
    MATERIALS AND METHODS:
    The cell viability was analyzed with DAPI. Flow cytometry and Western blot were used to study the apoptosis and cell cycle related mechanism. A rat model of bladder cancer was induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (OH-BBN). Tumors were analyzed with immunohistochemical analysis.
    RESULTS:
    Our data suggested that RPA inhibits growth of bladder cancer via induction of apoptosis and cell cycle arrest. Treatment of TSGH-8301 cells with RPA resulted in G2-M phase arrest that was associated with a marked decline in protein levels of cdc2, cyclin B1, cell division cycle 25B (Cdc25B) and Cdc25C. We also reported that RPA-mediated growth inhibition of TSGH-8301 cells was correlated with activation of checkpoint kinase 2 (Chk2). Herein, we further evaluated urinary bladder cancer using a model of bladder cancer induced by OH-BBN. Analysis of tumors from RPA-treated rats showed significant decrease in the expression of Bcl2, cyclin D1, and PCNA, and increase in the expression of p-Chk2 (Thr-68), Bax, and Cip1/p21.
    CONCLUSION:
    Our data provide the experimental evidence that RPA could modulate apoptosis in models of bladder cancer.
    Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
    URI: https://ir.csmu.edu.tw:8080/ir/handle/310902500/11186
    http://dx.doi.org/10.1016/j.jep.2011.03.011
    Relation: J Ethnopharmacol. 2011 Apr 26;135(1):162-72.
    Appears in Collections:[醫學系] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html期刊論文0KbHTML336View/Open


    SFX Query

    All items in CSMUIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback